title: Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide.
abstract: The proton relaxation effect of superparamagnetic iron oxide (SPIO) particles under varying conditions of spatial distribution was investigated with use of phantoms. Agar phantoms containing various concentrations of SPIO or gadopentetate dimeglumine, with and without Sephadex beads, were studied. Phantoms with Sephadex had a heterogeneous spatial distribution of iron oxide, comparable to liver tissue in vivo. Relaxometry at 0.47 T showed decreased T2 relaxivity of SPIO in Sephadex phantoms compared with that in agar phantoms without Sephadex. On T2-weighted images obtained at 1.5 T, the signal intensity of Sephadex phantoms showed less SPIO relaxation effect than that of plain agar phantoms. Unlike SPIO, gadopentetate dimeglumine showed the same relaxivities and signal intensity in plain agar and Sephadex phantoms. The results show that the T2 relaxation effect of iron oxide depends on its spatial distribution. A heterogeneous spatial distribution, as in intact liver tissue, diminishes the T2 relaxivity of iron oxide particles.
authors.affiliation: Department of Diagnostic Radiology, Keio University Hospital, Tokyo, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Tanimoto
authors.forename: D
authors.initials: D
authors.lastname: Pouliquen
authors.forename: B P
authors.initials: BP
authors.lastname: Kreft
authors.forename: D D
authors.initials: DD
authors.lastname: Stark
mesh_terms: D000362:Agar / Q000737:chemistry; D003287:Contrast Media / Q000737:chemistry*; D003911:Dextrans / Q000737:chemistry; D004338:Drug Combinations; D052203:Ferrosoferric Oxide; D005682:Gadolinium / Q000737:chemistry; D019786:Gadolinium DTPA; D005782:Gels / Q000737:chemistry; D006801:Humans; D007089:Image Enhancement; D007501:Iron / Q000737:chemistry*; D008099:Liver / Q000166:cytology; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D058185:Magnetite Nanoparticles; D008536:Meglumine / Q000737:chemistry; D008961:Models, Structural; D009942:Organometallic Compounds / Q000737:chemistry; D010087:Oxides / Q000737:chemistry*; D010316:Particle Size; D004369:Pentetic Acid / Q000031:analogs & derivatives / Q000737:chemistry; D011522:Protons; D012685:Sepharose / Q000737:chemistry; D013535:Suspensions
chemical_list: D003287:Contrast Media; D003911:Dextrans; D004338:Drug Combinations; D005782:Gels; D058185:Magnetite Nanoparticles; D009942:Organometallic Compounds; D010087:Oxides; D011522:Protons; D013535:Suspensions; D008536:Meglumine; D004369:Pentetic Acid; D000362:Agar; D012685:Sepharose; C025614:sephadex; D005682:Gadolinium; D007501:Iron; C065507:ferumoxides; D019786:Gadolinium DTPA; D052203:Ferrosoferric Oxide